mRNA Synthesis Raw Materials Market to Reach USD 2.67 Billion by 2032, Driven by Therapeutic Innovation – SNS Insider
Growing investments in mRNA vaccine and therapeutic platforms, along with regulatory acceleration, are fueling steady global demand for high-purity raw…